Rexulti, the first drug to relieve Alzheimer's emotions - TimesKuwait

The US Food and Drug Administration (FDA) has granted fast-track approval of the first drug aimed at relieving the emotions associated with Alzheimer’s disease. The FDA published, on its official website, a statement confirming the approval of Otsuka Pharmaceutical Company and Lundbeck, producers of oral Rexulti tablets to relieve the emotions associated with Alzheimer’s disease, […]

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Rexulti Approved for Agitation Associated With Dementia Due to Alzheimer Disease

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

FDA clears Rexulti as first drug for Alzheimer's agitation

Positive Data for First and Only Treatment Approved for Agitation in Alzheimer Dementia

US FDA approves Rexulti as first drug for agitation in Alzheimer's dementia